Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs
3M fa•
rialzista:
0
ribassista:
0
Condividi
The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.
3M fa•
rialzista:
0
ribassista:
0
Condividi
Gestisci cripto, NFT e DeFi in un unico luogoConnetti in sicurezza il portafoglio che usi per iniziare.